HHS redirects $500M to Trump appointee's vaccine project, bypassing reviews
Read Original Source
The Department of Health and Human Services has transferred $500 million from research into next-generation COVID-19 vaccines, redirecting the money to a single vaccine project linked to the Trump administration's former acting head of the National Institutes of Health. Multiple federal health officials said they were surprised by the announcement, which bypassed the usual procedures overseen by career scientists at the NIH and the Biomedical Advanced Research and Development Authority, known as BARDA.
AI Summary
Main Idea: HHS has moved $500 million from COVID-19 vaccine research to a single flu vaccine project, bypassing the usual scientific review process.
Key Points:
- The money was shifted to “Generation Gold Standard,” a project tied to former NIH acting head Matthew Memoli and overseen by NIH and BARDA officials.
- The plan aims to develop a universal flu vaccine, start human trials next year, and seek FDA approval by 2029.
- Federal health officials said the decision was unusual because it went to one platform with limited data and skipped normal career-scientist reviews.
- HHS says the move is a better use of Project NextGen money and fits its focus on broader flu preparedness and in-house vaccine development.
Impact on the People
Negative Impact
HHS shifting $500 million without normal scientific review could waste taxpayer money and weaken trust in vaccine decisions.
Positive Impact
The funding could speed work on a universal flu vaccine, which might help protect families if the project succeeds.
How did each entity affect people?
Rate how each entity in this article affected the American people.
No entity suggestions or linked entities saved yet.
Candidate Entities7 candidates · 5 weighted vote min · 70% decision
- Department of Health and Human Servicesgovernment agency or bodyPrimaryAI selected
Central agency that transferred the $500 million and made the funding decision.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Robert F. Kennedy Jr.personPrimaryAI selected
Health and Human Services Secretary tied to the decision and quoted defending the redirection.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Biomedical Advanced Research and Development Authoritygovernment agency or bodyMajorAI selected
Funding and review body mentioned as part of the bypassed procedure and the transfer.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Jeffery TaubenbergerpersonMajorAI selected
Named NIH researcher connected to the vaccine study and patent discussed in the funding shift.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Dr. Matthew MemolipersonMajorAI selected
Named NIH researcher whose project received the redirected funding and who is directly tied to the article’s central.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Food and Drug Administrationgovernment agency or bodyContextCandidate
Cited as the agency the project hopes to secure approval from, but not the main actor.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Noah MillerpersonContextCandidate
Named HHS special assistant who ordered the redirection of funds, but appears mainly in background reporting.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment